These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

241 related articles for article (PubMed ID: 10028405)

  • 1. Assessment of polystyrene extract for estrogenic activity in the rat uterotrophic model and an in vitro recombinant receptor reporter gene assay.
    Fail PA; Hines JW; Zacharewski T; Wu ZF; Borodinsky L
    Drug Chem Toxicol; 1998; 21 Suppl 1():101-21. PubMed ID: 10028405
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Uterotrophic assay of two concentrations of migrates from each of 23 polystyrenes administered orally (by gavage) to immature female Wistar rats.
    Bachmann S; Hellwig J; Jäckh R; Christian MS
    Drug Chem Toxicol; 1998; 21 Suppl 1():1-30. PubMed ID: 10028402
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Examination of the in vitro and in vivo estrogenic activities of eight commercial phthalate esters.
    Zacharewski TR; Meek MD; Clemons JH; Wu ZF; Fielden MR; Matthews JB
    Toxicol Sci; 1998 Dec; 46(2):282-93. PubMed ID: 10048131
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Variability in the uterotrophic response assay (an in vivo estrogenic response assay) in untreated control and positive control (DES-DP, 2.5 microG/kg, bid) Wistar and Sprague-Dawley rats.
    Christian MS; Hoberman AM; Bachmann S; Hellwig J
    Drug Chem Toxicol; 1998; 21 Suppl 1():51-100. PubMed ID: 10028404
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparative estrogenic effects of p-nonylphenol by 3-day uterotrophic assay and female pubertal onset assay.
    Kim HS; Shin JH; Moon HJ; Kang IH; Kim TS; Kim IY; Seok JH; Pyo MY; Han SY
    Reprod Toxicol; 2002; 16(3):259-68. PubMed ID: 12128099
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Potential estrogenic and antiestrogenic activity of the cyclic siloxane octamethylcyclotetrasiloxane (D4) and the linear siloxane hexamethyldisiloxane (HMDS) in immature rats using the uterotrophic assay.
    McKim JM; Wilga PC; Breslin WJ; Plotzke KP; Gallavan RH; Meeks RG
    Toxicol Sci; 2001 Sep; 63(1):37-46. PubMed ID: 11509742
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Estrogenic activity of a dieldrin/toxaphene mixture in the mouse uterus, MCF-7 human breast cancer cells, and yeast-based estrogen receptor assays: no apparent synergism.
    Ramamoorthy K; Wang F; Chen IC; Norris JD; McDonnell DP; Leonard LS; Gaido KW; Bocchinfuso WP; Korach KS; Safe S
    Endocrinology; 1997 Apr; 138(4):1520-7. PubMed ID: 9075711
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Failure of chloro-S-triazine-derived compounds to induce estrogen receptor-mediated responses in vivo and in vitro.
    Connor K; Howell J; Chen I; Liu H; Berhane K; Sciarretta C; Safe S; Zacharewski T
    Fundam Appl Toxicol; 1996 Mar; 30(1):93-101. PubMed ID: 8812239
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Validation of the intact rat weanling uterotrophic assay with notes on the formulation and analysis of the positive control chemical in vehicle.
    Tyl RW; Marr MC; Brown SS; Dolbow EA; Myers CB
    J Appl Toxicol; 2010 Oct; 30(7):694-8. PubMed ID: 20981862
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Evaluation of styrene oligomers eluted from polystyrene for estrogenicity in estrogen receptor binding assay, reporter gene assay, and uterotrophic assay.
    Ohno K; Azuma Y; Date K; Nakano S; Kobayashi T; Nagao Y; Yamada T
    Food Chem Toxicol; 2003 Jan; 41(1):131-41. PubMed ID: 12453737
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Naringenin: a weakly estrogenic bioflavonoid that exhibits antiestrogenic activity.
    Ruh MF; Zacharewski T; Connor K; Howell J; Chen I; Safe S
    Biochem Pharmacol; 1995 Oct; 50(9):1485-93. PubMed ID: 7503800
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The effects of phytoestrogens on neonatal rat uterine growth and development.
    Medlock KL; Branham WS; Sheehan DM
    Proc Soc Exp Biol Med; 1995 Mar; 208(3):307-13. PubMed ID: 7878071
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Immature rat uterotrophic assay of bisphenol A.
    Yamasaki K; Sawaki M; Takatsuki M
    Environ Health Perspect; 2000 Dec; 108(12):1147-50. PubMed ID: 11133394
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Potential estrogenic effects of bisphenol-A estimated by in vitro and in vivo combination assays.
    Kim HS; Han SY; Yoo SD; Lee BM; Park KL
    J Toxicol Sci; 2001 Aug; 26(3):111-8. PubMed ID: 11552294
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hydroxylated polychlorinated biphenyls (PCBs) as estrogens and antiestrogens: structure-activity relationships.
    Connor K; Ramamoorthy K; Moore M; Mustain M; Chen I; Safe S; Zacharewski T; Gillesby B; Joyeux A; Balaguer P
    Toxicol Appl Pharmacol; 1997 Jul; 145(1):111-23. PubMed ID: 9221830
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Examination of the estrogenicity of 2,4,6,2',6'-pentachlorobiphenyl (PCB 104), its hydroxylated metabolite 2,4,6,2',6'-pentachloro-4-biphenylol (HO-PCB 104), and a further chlorinated derivative, 2,4,6,2',4',6'-hexachlorobiphenyl (PCB 155).
    Fielden MR; Chen I; Chittim B; Safe SH; Zacharewski TR
    Environ Health Perspect; 1997 Nov; 105(11):1238-48. PubMed ID: 9370515
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Additive estrogenic activities of a binary mixture of 2',4',6'-trichloro- and 2',3',4',5'-tetrachloro-4-biphenylol.
    Ramamoorthy K; Vyhlidal C; Wang F; Chen I; Safe S; McDonnell DP; Leonard LS; Gaido KW
    Toxicol Appl Pharmacol; 1997 Nov; 147(1):93-100. PubMed ID: 9356311
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Preparation and analysis of styrene oligomers containing migrates from various polystyrenes used in food packaging.
    Klärner P; Klenz R; Eder R; Volz WE; Schnell HW; Leyendecker D; Güntner A; Niessner N; Morris CR; Christian MS
    Drug Chem Toxicol; 1998; 21 Suppl 1():31-49. PubMed ID: 10028403
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The efficacy of endocrine disruptor screening tests in detecting anti-estrogenic effects downstream of receptor-ligand interactions.
    Takeyoshi M; Yamasaki K; Sawaki M; Nakai M; Noda S; Takatsuki M
    Toxicol Lett; 2002 Jan; 126(2):91-8. PubMed ID: 11751013
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Uterotrophic assay of percutaneous lavender oil in immature female rats.
    Politano VT; McGinty D; Lewis EM; Hoberman AM; Christian MS; Diener RM; Api AM
    Int J Toxicol; 2013; 32(2):123-9. PubMed ID: 23358464
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.